The science is the story. We build the machine that tells it.
Marketing, credibility sites and data funnels for preclinical through clinical, platforms, tools and services — written for the science-literate buyer.
One brand. Every surface.
A concept launch for a fictional daily anti-aging skincare brand, taken all the way: identity, label and carton, retail shelf, unboxing, creator content and out-of-home — one visual system. And underneath the beauty: every signup wired into the CRM, labeled and attributed.
Identity · wordmark
Identity · reversed
MonogramKnow your baseline. Own it.
LUMEN-9 — the daily cellular serum. One bottle, AM and PM, against the look of aging.
Creator kit · UGC
Retail · shelf presence
Pack + carton · e-comm
Detail · label system
Unboxing · the kit
Lifestyle · the ritual
Thumb-stopping. Tested, not guessed.
The finished creator cut: an action hook in the first second, b-roll punch-cuts under a continuous voice, captions timed to her actual pauses, music ducked under the dialogue, and the baseline-dot sting to close. Then it went through an attention model and got re-cut until the curve held — hook variants tested head-to-head, winner shipped.
CONCEPT CAMPAIGN BY ZORM — LUMEN-9 is not a real product · no health claims · people and scenes are AI-generated for this concept.
Everything you publish is read four ways at once.
A press release, a pipeline update, a conference abstract, the website itself — each artifact is scored simultaneously by four different readers with four different questions. Generic agencies flatten this into hype. Internal teams drown it in jargon. The work is holding all four at once.
Scientists & KOLs
Is this rigorous?
One overstated claim and credibility is gone in the only community that talks to itself daily.
Investors
Is this momentum?
Milestones, runway and inflection points — legible in ninety seconds, defensible in diligence.
Pharma BD & partners
Does this fit our pipeline?
Mechanism, stage and data package findable without a meeting.
Talent
Is this a serious place to build a career?
The site is the first interview — scientists check it before they reply to the recruiter.
Three failure modes we see in growth-mode biotech.
Episodic marketing
The site gets rebuilt at each raise, goes quiet in between, and reads eighteen months stale exactly when a partner finally looks. Diligence rewards continuous signal, not bursts.
The jargon–hype trap
Copy either assumes a PhD or promises a miracle. Both lose: one reader bounces, the other — the scientist — quietly downgrades you.
Fragmented data
CRM, email tool, event scans, webinar platform and website all disconnected. Nobody can answer the only question that matters: which channel produced the partner meeting?
Six things we build for life-science teams.
Scoped as fixed-price engagements, delivered by one team — brand, engineering and operations together, the way the rest of Zorm works.
The Credibility Site
Your corporate site rebuilt as a diligence surface: the science story at two altitudes — expert and investor — team and track record, publications hub, and news discipline that makes momentum visible.
The Pipeline Page, done right
Per-program, per-phase, honest about position, readable by a non-scientist, structured for AI engines — with an update workflow so it never rots. A stale pipeline page is diligence poison.
Investor & Partner Funnel
Segmented nurture for investor, partner and KOL tracks; a milestone announcement engine that hits site, email and LinkedIn in one push; data-room requests that don't leak.
The Data Spine
One CRM as the source of truth: web, LinkedIn, email, webinars and conference badge scans all landing labeled by source, campaign and segment — with attribution a founder can read.
Conference Sprints
JPM Week, Biotech Showcase, BIO: the pre-week meeting funnel, on-site capture into the CRM the same day, and the 48-hour follow-up sequence that converts scans into meetings.
AI-Answer Visibility
When an investor asks ChatGPT or Claude about your space, be the answer: entity graph, llms.txt, FAQ corpus and query-shaped pages. We run this practice on zorm.io itself — you are probably reading the proof.
The pipeline page, the way diligence wants it.
Every program answers stage, indication framing and next milestone at a glance — expert detail one click deeper, and machine-readable underneath so AI engines quote it correctly instead of guessing.
FIG. 05A — vessels mark phase position, not promises. The update workflow keeps position current; the structured-data layer keeps machines honest about it.
One spine. Every channel. Every lead labeled.
This is the part most agencies can't build and most biotechs never get: the data layer that turns marketing from a cost line into an instrument. Zorm builds data platforms for a living — the same muscle behind Sentinel's federal-data pipelines, pointed at your funnel.
source · campaign · segment · stage
PROOF IN PRACTICE — submit the form below and your inquiry lands in our CRM labeled BioTech, source-tagged to this page, with your stage on the record. We run the spine we sell.
What we are — and what we are not.
Life sciences is allergic to overreach, so here is the position stated plainly. Our proof is adjacent, not sector-native: six software platforms designed, built and still operated in-house; data pipelines over HUD, Census and BLS datasets running in production; and delivered work for conservative buyers including the Department of Defense, IAT Insurance and Yardi. The discipline transfers. The first life-science client gets a team with everything to prove.
- One accountable team across brand, engineering and operations — no hand-offs
- A product company: we ship and run our own software, not just decks
- A data-engineering practice — pipelines, CRMs and attribution in production
- Claims-disciplined: review-ready workflows your legal team can sign fast
- A med-comms or medical-affairs agency
- A CRO, and not regulatory counsel — we never replace MLR or legal review
- A healthcare ad network buying HCP media
- Going to make a claim about your science. Ever.
Two seasons decide the year. Arrive with a machine.
JPM Week & Biotech Showcase sprint
The densest deal-making week in healthcare. We build the pre-week meeting-request funnel, the one-page company brief investors actually read, on-site capture into the CRM, and the 48-hour follow-up sequence — booked by November, live by New Year.
BIO International sprint
Partnering-system chaos, tamed: your partnering profile, booth capture and post-event nurture wired into the same spine, so June's scans are still alive in September.
What biotech teams ask us.
Do you work with preclinical companies?
Have you worked with biotech companies before?
Will you make claims about our science?
What does a biotech website cost?
Can you fix just our pipeline page?
What is the “data spine”?
Can you run our JPM Week or BIO presence?
Who owns the work?
Brief us. A human replies within one business day.
Five fields, no calendar link, no SDR sequence. Describe where you are and what has to be true at your next milestone — you'll get a reply with a point of view, including "you don't need us yet" when that's the honest answer.